Bronchodilator Efficacy of Single Doses of Indacaterol in Japanese Patients with COPD: A Randomised, Double-Blind, Placebo-Controlled Trial

Bronchodilator Efficacy of Single Doses of Indacaterol in Japanese Patients with COPD: A Randomised, Double-Blind, Placebo-Controlled Trial

ABSTRACT: Background: Indacaterol is an investigational, novel, inhaled once-daily ultra-long-acting beta-2 agonist for the treatment of chronic obstructive pulmonary disease (COPD). This study evaluated the 24-h bronchodilatory efficacy and safety of indacaterol in Japanese patients with COPD. Met...

Full description

Bibliographic Details
Main Authors: Motokazu Kato, Hironi Makita, Koji Uemura, Yoshinosuke Fukuchi, Motoi Hosoe, Charlotte Emery, Mark Higgins, Benjamin Kramer
Format: Article
Language:English
Published: Elsevier 2010-01-01
Series:Allergology International
Online Access:http://www.sciencedirect.com/science/article/pii/S1323893015306377

Internet

http://www.sciencedirect.com/science/article/pii/S1323893015306377

Similar Items